基于DNA甲基化的胶质细胞瘤分类与组织学和放射学协同作用,可完善精确的分子分层。

IF 4 2区 医学 Q1 CLINICAL NEUROLOGY
Thomas J Stone, Kshitij Mankad, Ai Peng Tan, Wajanat Jan, Jessica C Pickles, Maria Gogou, Jane Chalker, Iwona Slodkowska, Emily Pang, Mark Kristiansen, Gaganjit K Madhan, Leysa Forrest, Deborah Hughes, Eleni Koutroumanidou, Talisa Mistry, Olumide Ogunbiyi, Saira W Ahmed, J Helen Cross, Mike Hubank, Darren Hargrave, Thomas S Jacques
{"title":"基于DNA甲基化的胶质细胞瘤分类与组织学和放射学协同作用,可完善精确的分子分层。","authors":"Thomas J Stone, Kshitij Mankad, Ai Peng Tan, Wajanat Jan, Jessica C Pickles, Maria Gogou, Jane Chalker, Iwona Slodkowska, Emily Pang, Mark Kristiansen, Gaganjit K Madhan, Leysa Forrest, Deborah Hughes, Eleni Koutroumanidou, Talisa Mistry, Olumide Ogunbiyi, Saira W Ahmed, J Helen Cross, Mike Hubank, Darren Hargrave, Thomas S Jacques","doi":"10.1111/nan.12894","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Glioneuronal tumours (GNTs) are poorly distinguished by their histology and lack robust diagnostic indicators. Previously, we showed that common GNTs comprise two molecularly distinct groups, correlating poorly with histology. To refine diagnosis, we constructed a methylation-based model for GNT classification, subsequently evaluating standards for molecular stratification by methylation, histology and radiology.</p><p><strong>Methods: </strong>We comprehensively analysed methylation, radiology and histology for 83 GNT samples: a training cohort of 49, previously classified into molecularly defined groups by genomic profiles, plus a validation cohort of 34. We identified histological and radiological correlates to molecular classification and constructed a methylation-based support vector machine (SVM) model for prediction. Subsequently, we contrasted methylation, radiological and histological classifications in validation GNTs.</p><p><strong>Results: </strong>By methylation clustering, all training and 23/34 validation GNTs segregated into two groups, the remaining 11 clustering alongside control cortex. Histological review identified prominent astrocytic/oligodendrocyte-like components, dysplastic neurons and a specific glioneuronal element as discriminators between groups. However, these were present in only a subset of tumours. Radiological review identified location, margin definition, enhancement and T2 FLAIR-rim sign as discriminators. When validation GNTs were classified by SVM, 22/23 classified correctly, comparing favourably against histology and radiology that resolved 17/22 and 15/21, respectively, where data were available for comparison.</p><p><strong>Conclusions: </strong>Diagnostic criteria inadequately reflect glioneuronal tumour biology, leaving a proportion unresolvable. In the largest cohort of molecularly defined glioneuronal tumours, we develop molecular, histological and radiological approaches for biologically meaningful classification and demonstrate almost all cases are resolvable, emphasising the importance of an integrated diagnostic approach.</p>","PeriodicalId":19151,"journal":{"name":"Neuropathology and Applied Neurobiology","volume":"49 2","pages":"e12894"},"PeriodicalIF":4.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10946721/pdf/","citationCount":"0","resultStr":"{\"title\":\"DNA methylation-based classification of glioneuronal tumours synergises with histology and radiology to refine accurate molecular stratification.\",\"authors\":\"Thomas J Stone, Kshitij Mankad, Ai Peng Tan, Wajanat Jan, Jessica C Pickles, Maria Gogou, Jane Chalker, Iwona Slodkowska, Emily Pang, Mark Kristiansen, Gaganjit K Madhan, Leysa Forrest, Deborah Hughes, Eleni Koutroumanidou, Talisa Mistry, Olumide Ogunbiyi, Saira W Ahmed, J Helen Cross, Mike Hubank, Darren Hargrave, Thomas S Jacques\",\"doi\":\"10.1111/nan.12894\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>Glioneuronal tumours (GNTs) are poorly distinguished by their histology and lack robust diagnostic indicators. Previously, we showed that common GNTs comprise two molecularly distinct groups, correlating poorly with histology. To refine diagnosis, we constructed a methylation-based model for GNT classification, subsequently evaluating standards for molecular stratification by methylation, histology and radiology.</p><p><strong>Methods: </strong>We comprehensively analysed methylation, radiology and histology for 83 GNT samples: a training cohort of 49, previously classified into molecularly defined groups by genomic profiles, plus a validation cohort of 34. We identified histological and radiological correlates to molecular classification and constructed a methylation-based support vector machine (SVM) model for prediction. Subsequently, we contrasted methylation, radiological and histological classifications in validation GNTs.</p><p><strong>Results: </strong>By methylation clustering, all training and 23/34 validation GNTs segregated into two groups, the remaining 11 clustering alongside control cortex. Histological review identified prominent astrocytic/oligodendrocyte-like components, dysplastic neurons and a specific glioneuronal element as discriminators between groups. However, these were present in only a subset of tumours. Radiological review identified location, margin definition, enhancement and T2 FLAIR-rim sign as discriminators. When validation GNTs were classified by SVM, 22/23 classified correctly, comparing favourably against histology and radiology that resolved 17/22 and 15/21, respectively, where data were available for comparison.</p><p><strong>Conclusions: </strong>Diagnostic criteria inadequately reflect glioneuronal tumour biology, leaving a proportion unresolvable. In the largest cohort of molecularly defined glioneuronal tumours, we develop molecular, histological and radiological approaches for biologically meaningful classification and demonstrate almost all cases are resolvable, emphasising the importance of an integrated diagnostic approach.</p>\",\"PeriodicalId\":19151,\"journal\":{\"name\":\"Neuropathology and Applied Neurobiology\",\"volume\":\"49 2\",\"pages\":\"e12894\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10946721/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuropathology and Applied Neurobiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/nan.12894\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropathology and Applied Neurobiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/nan.12894","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:神经胶质细胞瘤(GNTs)很难通过组织学区分,也缺乏可靠的诊断指标。此前,我们曾发现常见的 GNT 包括两个分子上截然不同的群体,与组织学的相关性很低。为了完善诊断,我们构建了一个基于甲基化的 GNT 分类模型,随后评估了通过甲基化、组织学和放射学进行分子分层的标准:我们对 83 个 GNT 样本的甲基化、放射学和组织学进行了全面分析:其中 49 个样本为训练队列,之前已通过基因组图谱进行了分子分层;另外还有 34 个样本为验证队列。我们确定了分子分类的组织学和放射学相关性,并构建了一个基于甲基化的支持向量机 (SVM) 预测模型。随后,我们对验证组群的甲基化、放射学和组织学分类进行了对比:通过甲基化聚类,所有训练组和 23/34 验证组 GNT 分为两组,其余 11 组与对照组皮质聚类在一起。组织学检查发现,突出的星形胶质细胞/橄榄枝胶质细胞样成分、发育不良的神经元和一种特殊的神经胶质细胞元素是组间的区分因素。不过,这些成分只出现在一部分肿瘤中。放射学检查发现,位置、边缘定义、增强和 T2 FLAIR-rim 信号是判别因素。用 SVM 对验证的 GNT 进行分类时,有 22/23 例正确分类,与组织学和放射学的分类结果相比毫不逊色,在有数据可供比较的情况下,组织学和放射学的分类结果分别为 17/22 例和 15/21 例:结论:诊断标准不能充分反映神经胶质细胞肿瘤的生物学特性,导致一部分肿瘤无法确诊。在规模最大的分子定义胶质细胞瘤队列中,我们开发了分子、组织学和放射学方法,以进行具有生物学意义的分类,并证明几乎所有病例都能得到解决,强调了综合诊断方法的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

DNA methylation-based classification of glioneuronal tumours synergises with histology and radiology to refine accurate molecular stratification.

DNA methylation-based classification of glioneuronal tumours synergises with histology and radiology to refine accurate molecular stratification.

Aims: Glioneuronal tumours (GNTs) are poorly distinguished by their histology and lack robust diagnostic indicators. Previously, we showed that common GNTs comprise two molecularly distinct groups, correlating poorly with histology. To refine diagnosis, we constructed a methylation-based model for GNT classification, subsequently evaluating standards for molecular stratification by methylation, histology and radiology.

Methods: We comprehensively analysed methylation, radiology and histology for 83 GNT samples: a training cohort of 49, previously classified into molecularly defined groups by genomic profiles, plus a validation cohort of 34. We identified histological and radiological correlates to molecular classification and constructed a methylation-based support vector machine (SVM) model for prediction. Subsequently, we contrasted methylation, radiological and histological classifications in validation GNTs.

Results: By methylation clustering, all training and 23/34 validation GNTs segregated into two groups, the remaining 11 clustering alongside control cortex. Histological review identified prominent astrocytic/oligodendrocyte-like components, dysplastic neurons and a specific glioneuronal element as discriminators between groups. However, these were present in only a subset of tumours. Radiological review identified location, margin definition, enhancement and T2 FLAIR-rim sign as discriminators. When validation GNTs were classified by SVM, 22/23 classified correctly, comparing favourably against histology and radiology that resolved 17/22 and 15/21, respectively, where data were available for comparison.

Conclusions: Diagnostic criteria inadequately reflect glioneuronal tumour biology, leaving a proportion unresolvable. In the largest cohort of molecularly defined glioneuronal tumours, we develop molecular, histological and radiological approaches for biologically meaningful classification and demonstrate almost all cases are resolvable, emphasising the importance of an integrated diagnostic approach.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.20
自引率
2.00%
发文量
87
审稿时长
6-12 weeks
期刊介绍: Neuropathology and Applied Neurobiology is an international journal for the publication of original papers, both clinical and experimental, on problems and pathological processes in neuropathology and muscle disease. Established in 1974, this reputable and well respected journal is an international journal sponsored by the British Neuropathological Society, one of the world leading societies for Neuropathology, pioneering research and scientific endeavour with a global membership base. Additionally members of the British Neuropathological Society get 50% off the cost of print colour on acceptance of their article.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信